SHL Telemedicine Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

David Arnon

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	1.6yrs
Gemiddelde ambtstermijn bestuur	6.7yrs

Recente managementupdates

Recent updates

Market Cool On SHL Telemedicine Ltd.'s (VTX:SHLTN) Revenues Pushing Shares 27% Lower

Oct 10

Investors Give SHL Telemedicine Ltd. (VTX:SHLTN) Shares A 32% Hiding

Aug 21

Market Participants Recognise SHL Telemedicine Ltd.'s (VTX:SHLTN) Revenues Pushing Shares 30% Higher

Jun 04

SHL Telemedicine Ltd. (VTX:SHLTN) Not Lagging Industry On Growth Or Pricing

Apr 20

We Think SHL Telemedicine Ltd.'s (VTX:SHLTN) CEO Compensation Package Needs To Be Put Under A Microscope

Dec 01

Is SHL Telemedicine (VTX:SHLTN) A Risky Investment?

Oct 28

Is SHL Telemedicine (VTX:SHLTN) Using Debt In A Risky Way?

Jun 23

SHL Telemedicine Ltd.'s (VTX:SHLTN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Mar 05

Are SHL Telemedicine's (VTX:SHLTN) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 12

What Percentage Of SHL Telemedicine Ltd. (VTX:SHLTN) Shares Do Insiders Own?

Jan 21

Investors Who Bought SHL Telemedicine (VTX:SHLTN) Shares A Year Ago Are Now Up 120%

Jan 04

What Do The Returns At SHL Telemedicine (VTX:SHLTN) Mean Going Forward?

Dec 01

CEO

David Arnon (54 yo)

less than a year

Tenure

Mr. David Arnon serves as Chief Executive Officer at SHL Telemedicine Ltd. since August 06, 2024. He had been Deputy Chief Executive Officer and Director of Health and Customer System Division at Clal Insu...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
David Arnon	Chief Executive Officer	less than a year	geen gegevens	geen gegevens
Amir Hai	Chief Financial Officer	2.8yrs	geen gegevens	geen gegevens
Bernd Altpeter	Managing Director of SHL Telemedizin Germany	1.6yrs	geen gegevens	geen gegevens

1.6yrs

Gemiddelde duur

Ervaren management: Het managementteam van SHLTN wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.6 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Susan Alpert	USA Advisory Board Member	no data	geen gegevens	geen gegevens
Dvorah Kimhi	Independent External Director	5.9yrs	US$46.13k	geen gegevens
Irit Alroy	Israel Advisory Board Member	no data	geen gegevens	geen gegevens
Yehoshua Abramovich	Independent External Director	7.4yrs	US$85.51k	0.10% CHF 42.1k
Amir Lerman	Independent Non-Executive Director	8.8yrs	US$44.85k	0.035% CHF 14.1k
Itamar Offer	Chairman	less than a year	geen gegevens	geen gegevens
Martin Lehner	Germany Advisory Board Member	no data	geen gegevens	geen gegevens
Helmut Platzer	Germany Advisory Board Member	no data	geen gegevens	geen gegevens
Claus Moldenhauer	Germany Advisory Board Member	no data	geen gegevens	geen gegevens
Andrei Soran	USA Advisory Board Member	no data	geen gegevens	geen gegevens
Robert Brooks	USA Advisory Board Member	no data	geen gegevens	geen gegevens
Michal Golovner	Israel Advisory Board Member	no data	geen gegevens	geen gegevens

6.7yrs

Gemiddelde duur

69.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van SHLTN wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.7 jaar).

SHL Telemedicine Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

SHL Telemedicine Ltd. Appoints David Arnon as CEO, Effective from August 6, 2024

SHL Telemedicine Ltd. Announces Erez Nachtomy, to Steps Down as CEO in Mid-June 2024

Insufficient new directors

SHL Telemedicine Ltd. Announces Board Changes

SHL Telemedicine Ltd. Announces Board Changes

SHL Telemedicine Ltd., Annual General Meeting, Feb 08, 2024

Recent updates

New major risk - Revenue and earnings growth

Market Cool On SHL Telemedicine Ltd.'s (VTX:SHLTN) Revenues Pushing Shares 27% Lower

First half 2024 earnings released: US$0.24 loss per share (vs US$0.14 loss in 1H 2023)

New minor risk - Profitability

Investors Give SHL Telemedicine Ltd. (VTX:SHLTN) Shares A 32% Hiding

SHL Telemedicine Ltd. Appoints David Arnon as CEO, Effective from August 6, 2024

Market Participants Recognise SHL Telemedicine Ltd.'s (VTX:SHLTN) Revenues Pushing Shares 30% Higher

SHL Telemedicine Ltd. to Report First Half, 2024 Results on Sep 26, 2024

SHL Telemedicine Ltd. (VTX:SHLTN) Not Lagging Industry On Growth Or Pricing

Full year 2023 earnings released: US$0.43 loss per share (vs US$0.005 loss in FY 2022)

Forecast to breakeven in 2025

SHL Telemedicine Ltd. Announces Full Results of the Imperial College London Tele-ACS Trial

SHL Telemedicine's SmartHeart Technology Triumphs in US Army Project Convergence - Capstone 4 Experiment

New minor risk - Financial data availability

SHL Telemedicine Ltd. Announces Erez Nachtomy, to Steps Down as CEO in Mid-June 2024

Value Base Ltd Provides Information to Shareholders of SHL Telemedicine

New minor risk - Market cap size

Insufficient new directors

SHL Telemedicine Ltd. Announces Board Changes

SHL Telemedicine Ltd. Announces Board Changes

SHL Telemedicine Ltd. to Report Fiscal Year 2023 Results on Apr 17, 2024

SHL Telemedicine Ltd., Annual General Meeting, Feb 08, 2024

Danbar Finance Nominates a Candidate to the Board of SHL Telemedicine

We Think SHL Telemedicine Ltd.'s (VTX:SHLTN) CEO Compensation Package Needs To Be Put Under A Microscope

Is SHL Telemedicine (VTX:SHLTN) A Risky Investment?

Shl Telemedicine Ltd. Announces the Initial Results from the Mayo Clinic Help-Mi and the Imperial College London Tele-Acs Trials

First half 2023 earnings released: US$0.14 loss per share (vs US$0.002 profit in 1H 2022)

Is SHL Telemedicine (VTX:SHLTN) Using Debt In A Risky Way?

Full year 2022 earnings released

SHL Telemedicine Ltd., Annual General Meeting, Dec 07, 2023

Less than half of directors are independent

SHL Telemedicine Ltd. Appoints Kimberly J. Henderson and Joshua H. Atkins to its US Advisory Board

SHL Telemedicine Ltd. Appoints Ehud Barak as Co-Chairman

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues miss analyst expectations

SHL Telemedicine Ltd. to Report Fiscal Year 2021 Results on Apr 14, 2022

SHL Telemedicine Ltd. to Report First Half, 2022 Results on Sep 22, 2022

First half 2021 earnings released: US$0.75 loss per share (vs US$0.01 profit in 1H 2020)

SHL Telemedicine Ltd completed the acquisition of a 70% stake in Mediton Medical Centers Ltd.

SHL Telemedicine Ltd. (SWX:SHLTN) signed an agreement to acquire 70% of the Mediton Group companies for ILS 84 million ($26 million).

Full year 2020 earnings released: EPS US$0.03 (vs US$0.54 in FY 2019)

SHL Telemedicine Ltd.'s (VTX:SHLTN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

SHL Telemedicine Announces Executive Changes

Are SHL Telemedicine's (VTX:SHLTN) Statutory Earnings A Good Guide To Its Underlying Profitability?

What Percentage Of SHL Telemedicine Ltd. (VTX:SHLTN) Shares Do Insiders Own?

SHL Telemedicine Ltd. Files Pre-Submission with FDA for over the Counter Clearance of SHL’S Smartheart™ Full 12 Lead ECG

Investors Who Bought SHL Telemedicine (VTX:SHLTN) Shares A Year Ago Are Now Up 120%

New 90-day high: CHF10.90

Investor sentiment improved over the past week

What Do The Returns At SHL Telemedicine (VTX:SHLTN) Mean Going Forward?

New 90-day high: CHF8.80

SHL Telemedicine to Launch Doctors’ Virtual Visits with Health Insurance Company BARMER

AI Tool Jointly Develops by Hadassah Medical Center – SHL Telemedicine – Hebrew University

Market bids up stock over the past week

New 90-day high: CHF6.80

Market bids up stock over the past week

Mayo Clinic Collaborates with SHL Telemedicine using SmartHeart™ Technology 12 lead ECG

New 90-day high: CHF5.90

First half earnings released

New 90-day low - CHF5.30

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd